Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketogenic Dietary Therapy for New-onset Childhood Absence Epilepsy
NCT04274179Phase 3Recruiting
- Sponsor
- Johns Hopkins University
- Start
- Aug 2020
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Phase 3, open-label trial in childhood absence epilepsy (CAE) (2 arms), sponsored by Johns Hopkins University. Primary endpoint: Change in seizure frequency at 3 months. Started Aug 2020; status: recruiting.
02
Conditions
childhood absence epilepsy (CAE)
Beyond the preview
Go deeper on NCT04274179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04274179.